• Профилактика и менеджмент послеродовых кровотечений
ru К содержанию

Профилактика и менеджмент послеродовых кровотечений

HEALTH OF WOMAN.2017.1(117):145–157

Опубликовано: Green-top Guideline No. 52 December 2016
Сокращенный вариант. Адаптировано – С.А. Шурпяк


1. Scottish Obstetric Guidelines and Audit Project. The Management of Postpartum Haemorrhage: A Clinical Practice Guideline for Professionals involved in Maternity Care in Scotland. Pilot edition. Glasgow: SOGAP, 1998. [http://healthcareimprovementscotland. org/his/idoc.ashx?docid=84ee51e6-d441-4dba-8ebf-4fa6a2857e0d& version=-1]. Accessed 2015 Jul 2.

2. Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2014;(2):CD003249. https://doi.org/10.1002/14651858.cd003249.pub3

3. Knight M, Tuffnell D, Kenyon S, Shakespeare J, Gray R, Kurinczuk JJ, editors, on behalf of MBRRACE-UK. Saving Lives, Improving Mothers’ Care – Surveillance of maternal deaths in the UK 2011-13 and lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009–13. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2015.

4. Alexander J, Thomas PW, Sanghera J. Treatments for secondary postpartum haemorrhage. Cochrane Database Syst Rev 2002;(1): CD002867. https://doi.org/10.1002/14651858.cd002867

5. Demers C, Derzko C, David M, Douglas J; Society of Obstetricians and Gynaecologists of Canada. Gynae-cological and obstetric management of women with inherited bleeding disorders. SOGC Clinical Practice Guidelines No 163. J Obstet Gynaecol Can 2005; 27:707–18. https://doi.org/10.1016/S1701-2163(16)30551-5

6. Baudo F, de Cataldo F; Italian Association of Haemophilia Centres (AICE): Register of acquired factor VIII inhibitors (RIIA). Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Register relevant to clinical practice. BJOG 2003; 110: 311–4. https://doi.org/10.1016/S1470-0328(03)01935-9; https://doi.org/10.1046/j.1471-0528.2003.01535.x; PMid:12628274

7. The Royal College of Surgeons of England. Code of Practice for the Surgical Management of Jehovah’s Witnesses. London: The Royal College of Surgeons of England; 2002.

8. The Association of Anaesthetists of Great Britain and Ireland. Management of Anaesthesia for Jehovah’s Witnesses, 2nd ed. London: AAGBI; 2005.

9. National Institute for Health and Care Excellence. Intrapartum care: care of healthy women and their babies during childbirth. NICE clinical guideline 190. Manchester: NICE; 2014.

10. Centre for Maternal and Child Enquiries (CMACE). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006–08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118 Suppl 1:1–203.

11. Royal College of Obstetricians and Gynaecologists. Antepartum Haemorrhage. Green-top Guideline No. 63. London: RCOG; 2011.

12. Royal College of Obstetricians and Gynaecologists. Placenta ?Praevia, Placenta Praevia Accreta and Vasa Praevia: Diagnosis and ?Management. Green-top Guideline No. 27. London: RCOG; 2011.

13. Royal College of Obstetricians and Gynaecologists. Blood Transfusion in Obstetrics. Green-top Guideline No. 47. London: ?RCOG; 2015.

14. Calvert C, Thomas SL, Ronsmans C, Wagner KS, Adler AJ, Filippi V. Identifying regional variation in the prevalence of postpartum haemorrhage: a systematic review and meta-analysis. PLoS ONE 2012;7 :e41114. https://doi.org/10.1371/journal.pone.0041114: PMid:22844432 PMCid:PMC3402540

15. Bryant A, Mhyre JM, Leffert LR, Hoban RA, Yakoob MY, Bateman BT. The association of maternal race and ethnicity and the risk of postpartum hemorrhage. Anesth Analg 2012; 115: 1127–36. https://doi.org/10.1213/ANE.0b013e3182691e62; PMid:22886840

16. Combs CA, Murphy EL, Laros RK Jr. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991;77:69–76. PMid:1984230

17. Stones RW, Paterson CM, Saunders NJ. Risk factors for major obstetric haemorrhage. Eur J Obstet Gynecol Reprod Biol 1993;48:15–8. https://doi.org/10.1016/0028-2243(93)90047-G

18. Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. Prevalence and risk factors of severe obstetric haemorrhage. BJOG 2008;115:1265–72. https://doi.org/10.1111/j.1471-0528.2008.01859.x; PMid:18715412

19. Tsu VD. Postpartum haemorrhage in Zimbabwe: a risk factor analysis. Br J Obstet Gynaecol 1993;100:327–33. https://doi.org/10.1111/j.1471-0528.1993.tb12974.x; PMid:8494833

20. Bais JM, Eskes M, Pel M, Bonsel GJ, Bleker OP. Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard (≥500 ml) and severe (≥1000 ml) postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2004;115:166–72. https://doi.org/10.1016/j.ejogrb.2003.12.008

21. Magann EF, Evans S, Hutchinson M, Collins R, Howard BC, Morrison JC. Postpartum hemorrhage after vaginal birth: an analysis of risk factors. South Med J 2005;98:419–22. https://doi.org/10.1097/01.SMJ.0000152760.34443.86; https://doi.org/10.1097/01.SMJ.0000163309.53317.B8

22. Magann EF, Evans S, Chauhan SP, Lanneau G, Fisk AD, Morrison JC. The length of the third stage of labor and the risk of postpartum hemorrhage. Obstet Gynecol 2005;105:290–3. https://doi.org/10.1097/01.AOG.0000151993.83276.70; PMid:15684154

23. Sheiner E, Sarid L, Levy A, Seidman DS, Hallak M. Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population-based study. J Matern Fetal Neonatal Med 2005;18:149–54. https://doi.org/10.1080/14767050500170088; PMid:16272036

24. Sosa CG, Althabe F, Beliz an JM, Buekens P. Risk factors for postpartum hemorrhage in vaginal deliveries in a Latin-American population. Obstet Gynecol 2009;113:1313–9. https://doi.org/10.1097/AOG.0b013e3181a66b05; PMid:19461428 PMCid:PMC2730945

25. Brinsden PR, Clark AD. Postpartum haemorrhage after induced and spontaneous labour. Br Med J 1978; ii:855–6. https://doi.org/10.1136/bmj.2.6141.855

26. Selo-Ojeme DO, Okonofua FE. Risk factors for primary postpartum haemorrhage. A case control study. Arch Gynecol Obstet 1997;259:179–87. https://doi.org/10.1007/BF02505330; PMid:9271837

27. World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: WHO; 2012.

28. Oyelese Y, Ananth CV. Postpartum hemorrhage: epidemiology, risk factors, and causes. Clin Obstet Gynecol 2010;53:147–56. https://doi.org/10.1097/GRF.0b013e3181cc406d; PMid:20142652

29. Confidential Enquiry into Maternal and Child Health. Why Mothers Die 2000–2002. The Sixth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: RCOG Press; 2004.

30. Leduc D, Senikas V, Lalonde AB, Ballerman C, Biringer A, Delaney M, et al.; Clinical Practice Obstetrics Committee; Society of Obstetricians and Gynaecologists of Canada. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. SOGC Clinical Practice Guideline No. 235. J Obstet Gynaecol Can 2009;31:980–93. https://doi.org/10.1016/S1701-2163(16)34329-8

31. Combs CA, Murphy EL, Laros RK Jr. Factors associated with hemorrhage in cesarean deliveries. Obstet Gynecol 1991;77: 77–82. https://doi.org/10.1097/00006254-199106000-00011

32. National Institute for Health and Care Excellence. Antenatal Care. NICE clinical guideline 62. Manchester: NICE; 2008.

33. Pavord S, Myers B, Robinson S, Allard S, Strong J, Oppenheimer C; British Committee for Standards in Haematology. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol 2012; 156: 588–600. https://doi.org/10.1111/j.1365-2141.2011.09012.x; PMid:22512001

34. Kavle JA, Stoltzfus RJ, Witter F, Tielsch JM, Khalfan SS, Caulfield LE. Association between anaemia during pregnancy and blood loss at and after delivery among women with vaginal births in Pemba Island, Zanzibar, Tanzania. J Health Popul Nutr 2008;26:232–40. PMid:18686556 PMCid:PMC2740668

35. Hofmeyr GJ, Abdel-Aleem H, Abdel-Aleem MA. Uterine massage for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2013;(7):CD006431. https://doi.org/10.1002/14651858.cd006431.pub3

36. McDonald SJ, Abbott JM, Higgins SP. Prophylactic ergometrine– oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev 2004;(1):CD000201. https://doi.org/10.1002/14651858.cd000201.pub2

37. Tun»calp O, Hofmeyr GJ, G€ulmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2012; (8): CD000494. https://doi.org/10.1002/14651858.cd000494.pub4

38. Oladapo OT, Fawole B, Blum J, Abalos E. Advance misoprostol distribution for preventing and treating postpartum haemorrhage. Cochrane Database Syst Rev 2012; (2): CD009336. https://doi.org/10.1002/14651858.cd009336.pub2

39. Begley CM, Gyte GM, Devane D, McGuire W, Weeks A. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev 2011; (11): CD007412. https://doi.org/10.1002/14651858.cd007412.pub3

40. Hutton EK, Hassan ES. Late vs early clamping of the umbilical cord in full-term neonates: systematic review and meta-analysis of controlled trials. JAMA 2007;297:1241–52. https://doi.org/10.1001/jama.297.11.1241; PMid:17374818

41. Royal College of Obstetricians and Gynaecologists. Clamping of the Umbilical Cord and Placental Transfusion. Scientific Impact Paper No. 14. London: RCOG; 2015.

42. Tita AT, Szychowski JM, Rouse DJ, Bean CM, Chapman V, Nothern A, et al. Higher-dose oxytocin and hemorrhage after vaginal delivery: a randomized controlled trial. Obstet Gynecol 2012;119:293–300. https://doi.org/10.1097/AOG.0b013e318242da74; PMid:22227638 PMCid:PMC3282278

43. Gizzo S, Patrelli TS, Di Gangi S, Carrozzini M, Saccardi C, Zambon A, et al. Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review. Reprod Sci 2013; 20: 1011–9. https://doi.org/10.1177/1933719112468951; PMid:23296037

44. Su LL, Chong YS, Samuel M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2012;(4): CD005457. https://doi.org/10.1002/14651858.cd005457.pub3

45. Dennehy KC, Rosaeg OP, Cicutti NJ, Krepski B, Sylvain JP. Oxytocin injection after caesarean delivery: intravenous or intramyometrial? Can J Anaesth 1998;45:635–9. https://doi.org/10.1007/BF03012092; PMid:9717594

46. Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC. Comparison of two oxytocin regimens to prevent uterine atony at caesarean delivery: a randomized controlled trial. Obstet Gynecol 2001;98:386–90. https://doi.org/10.1016/S0029-7844(01)01479-X; https://doi.org/10.1097/00006250-200109000-00005; PMid:11530117

47. Lokugamage AU, Paine M, Bassaw-Balroop K, Sullivan KR, El Refaey H, Rodeck CH. Active management of the third stage at caesarean section: a randomised controlled trial of misoprostol versus Syntocinon. Aust N Z J Obstet Gynaecol 2001;41:411–4. https://doi.org/10.1111/j.1479-828X.2001.tb01319.x; PMid:11787915

48. Chou MM, MacKenzie IZ. A prospective, double-blind, randomized comparison of prophylactic intramyometrial 15-methyl prostaglandin F2a, 125 micrograms, and intravenous oxytocin, 20 units, for the control of blood loss at elective cesarean section. Am J Obstet Gynecol 1994;171:1356–60. https://doi.org/10.1016/0002-9378(94)90160-0

49. Boucher M, Horbay GL, Griffin P, Deschamps Y, Desjardins C, Schulz M, et al. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section. J Perinatol 1998; 18:202–7. PMid:9659650

50. Dansereau J, Joshi AK, Helewa ME, Doran TA, Lange IR, Luther ER, et al. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section. Am J Obstet Gynecol 1999;180:670–6. https://doi.org/10.1016/S0002-9378(99)70271-1

51. National Collaborating Centre for Women’s and Children’s Health. Caesarean Section. London: RCOG; 2011.

52. Novikova N, Hofmeyr GJ, Cluver C. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2015; (6): CD007872. https://doi.org/10.1002/14651858.cd007872.pub3

53. Glover P. Blood loss at delivery: how accurate is your estimation? Aust J Midwifery 2003;16:21–4. https://doi.org/10.1016/S1031-170X(03)80005-3

54. Toledo P, McCarthy RJ, Hewlett BJ, Fitzgerald PC, Wong CA. The accuracy of blood loss estimation after simulated vaginal delivery. Anesth Analg 2007;105:1736–40. https://doi.org/10.1213/01.ane.0000286233.48111.d8; PMid:18042876

55. Patel A, Goudar SS, Geller SE, Kodkany BS, Edlavitch SA, Wagh K, et al. Drape estimation vs. visual assessment for estimating postpartum hemorrhage. Int J Gynaecol Obstet 2006; 93: 220–4. https://doi.org/10.1016/j.ijgo.2006.02.014; PMid:16626718

56. Schorn MN. Measurement of blood loss: review of the literature. J Midwifery Womens Health 2010; 55:20–7. https://doi.org/10.1016/j.jmwh.2009.02.014; PMid:20129226

57. Zhang WH, Deneux-Tharaux C, Brocklehurst P, Juszczak E, Joslin M, Alexander S; EUPHRATES Group. Effect of a collector bag for measurement of postpartum blood loss after vaginal delivery: cluster randomised trial in 13 European countries. BMJ 2010; 340: c293. https://doi.org/10.1136/bmj.c293; PMid:20123835 PMCid:PMC2815270

58. Buckland SS, Homer CS. Estimating blood loss after birth: using simulated clinical examples. Women Birth 2007;20:85–8. https://doi.org/10.1016/j.wombi.2007.01.001; PMid:17320496

59. Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG 2006;113:919–24. https://doi.org/10.1111/j.1471-0528.2006.01018.x; PMid:16907938

60. Rath WH. Postpartum hemorrhage – update on problems of definitions and diagnosis. Acta Obstet Gynecol Scand 2011;90:421–8. https://doi.org/10.1111/j.1600-0412.2011.01107.x; PMid:21332452

61. Allgo€wer M, Burri C. [“Shock index”]. Dtsch Med Wochenschr 1967;92:1947–50. German. https://doi.org/10.1055/s-0028-1106070; PMid:5299769

62. Nathan HL, El Ayadi A, Hezelgrave NL, Seed P, Butrick E, Miller S, et al. Shock index: an effective predictor of outcome in postpartum haemorrhage? BJOG 2015;122:268–75. https://doi.org/10.1111/1471-0528.13206; PMid:25546050

63. Royal College of Obstetricians and Gynaecologists. Responsibility of Consultant On-Call. Good Practice No. 8. London: RCOG; 2009.

64. Duthie SJ, Ven D, Yung GL, Guang DZ, Chan SY, Ma HK. Discrepancy between laboratory determination and visual estimation of blood loss during normal delivery. Eur J Obstet Gynecol Reprod Biol 1991;38:119–24. https://doi.org/10.1016/0028-2243(91)90188-Q

65. Ho AM, Karmakar MK, Dion PW. Are we giving enough coagulation factors during major trauma resuscitation? Am J Surg 2005;190:479–84. https://doi.org/10.1016/j.amjsurg.2005.03.034; PMid:16105540

66. Hirshberg A, Dugas M, Banez EI, Scott BG, Wall MJ Jr, Mattox KL. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma 2003; 54: 454–63. https://doi.org/10.1097/01.TA.0000053245.08642.1F; PMid:12634523

67. Hunt BJ, Allard S, Keeling D, Norfolk D, Stanworth SJ, Pendry K; British Committee for Standards in Haematology. A practical guideline for the haematological management of major haemorrhage. Br J Haematol 2015;170:788–803. https://doi.org/10.1111/bjh.13580; PMid:26147359

68. British Committee for Standards in Haematology, Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ. Guidelines on the management of massive blood loss. Br J Haematol 2006; 135: 634–41. https://doi.org/10.1111/j.1365-2141.2006.06355.x; PMid:17107347

69. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998;317:235–40. https://doi.org/10.1136/bmj.317.7153.235; PMid:9677209 PMCid:PMC28613

70. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 1998;316:961–4. https://doi.org/10.1136/bmj.316.7136.961; PMid:9550953 PMCid:PMC28497

71. Association of Anaesthetists of Great Britain and Ireland, Thomas D, Wee M, Clyburn P, Walker I, Brohi K, et al. Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia 2010; 65:1153–61. https://doi.org/10.1111/j.1365-2044.2010.06538.x; PMCid:PMC3032944

72. Luna GK, Maier RV, Pavlin EG, Anardi D, Copass MK, Oreskovich MR. Incidence and effect of hypothermia in seriously injured patients. J Trauma 1987;27:1014–8. https://doi.org/10.1097/00005373-198709000-00010; PMid:3656463

73. World Health Organization. WHO guidelines for the management of postpartum haemorrhage and retained placenta. Geneva: WHO; 2009. [http: //apps.who.int/iris/bitstream/ 10665/ 44171/1/978924159– 8514_eng.pdf]. Accessed 2016 Feb 4.

74. Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013; (2): CD000567. https://doi.org/10.1002/14651858.cd000567.pub6

75. Murphy MF, Wallington TB, Kelsey P, Boulton F, Bruce M, Cohen H, et al.; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the clinical use of red cell transfusions. Br J Haematol 2001;113:24–31. https://doi.org/10.1046/j.1365-2141.2001.02701.x; PMid:11328275

76. United Kingdom Blood Services; Norfolk D, editor. Handbook of Transfusion Medicine. 5th ed. Norwich: TSO; 2013.

77. Serious Hazards of Transfusion (SHOT). [www.shotuk.org/]. Accessed 2013 Aug 6.

78. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013;30:270–382. https://doi.org/10.1097/EJA.0b013e32835f4d5b; PMid:23656742

79. British Committee for Standards in Haematology, Milkins C, Berryman J, Cantwell C, Elliott C, Haggas R, et al. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. Transfus Med 2013; 23:3–35. https://doi.org/10.1111/j.1365-3148.2012.01199.x; PMid:23216974

80. Royal College of Obstetricians and Gynaecologists. The Management of Women with Red Cell Antibodies during Pregnancy. Green-top Guideline No. 65. London: RCOG; 2014.

81. Laupacis A, Brown J, Costello B, Delage G, Freedman J, Hume H, et al. Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement. Transfusion 2001;41: 560–9. https://doi.org/10.1046/j.1537-2995.2001.41040560.x; PMid:11316911

82. Advisory Committee on the Safety of Blood, Tissues and Organs. Cytomegalovirus tested blood components – position statement. London: Department of Health; 2012.

83. Carless PA, Henry DA, Moxey AJ, O’Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010; (4):CD001888. https://doi.org/10.1002/14651858.cd001888.pub3

84. Catling SJ, Williams S, Fielding AM. Cell salvage in obstetrics: an evaluation of the ability of cell salvage combined with leucocyte depletion filtration to remove amniotic fluid from operative blood loss at caesarean section. Int J Obstet Anesth 1999;8:79–84. https://doi.org/10.1016/S0959-289X(99)80002-8

85. National Institute for Health and Clinical Excellence. Intraoperative blood cell salvage in obstetrics. NICE interventional procedure guidance 144. Manchester: NICE; 2005.

86. Wee MY, Thomas D, Verma R, Jones J, Catling S, Isaac J, et al.; The Association of Anaesthetists of Great Britain and Ireland. Blood Transfusion and the Anaesthetist: Intra-operative Cell Salvage. AAGBI Safety Guideline. London: AAGBI; 2009.

87. Liumbruno GM, Liumbruno C, Rafanelli D. Intraoperative cell salvage in obstetrics: is it a real therapeutic option? Transfusion 2011;51:2244–56. https://doi.org/10.1111/j.1537-2995.2011.03116.x; PMid:21446940

88. Geoghegan J, Middleton L, Moore P, Subseson G, Khan K, Daniels J. Routine cell salvage during elective caesarean section: a pilot randomised trial. Int J Obstet Anesth 2015; 24:86–7. https://doi.org/10.1016/j.ijoa.2014.08.003; PMid:25499013

89. Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth 2012;109:851–63. https://doi.org/10.1093/bja/aes361; PMid:23075633 PMCid:PMC3498756

90. Avidan MS, Alcock EL, Da Fonseca J, Ponte J, Desai JB, Despotis GJ, et al. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 2004; 92:178–86. https://doi.org/10.1093/bja/aeh037; PMid:14722166

91. Allard S, Green L, Hunt BJ. How we manage the haematological aspects of major obstetric haemorrhage. Br J Haematol 2014; 164:177–88. https://doi.org/10.1111/bjh.12605; PMid:24383841

92. Bell SF, Rayment R, Collins PW, Collis RE. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int J Obstet Anesth 2010;19:218–23.

93. Collis RE, Collins PW. Haemostatic management of obstetric haemorrhage. Anaesthesia 2015;70 Suppl 1:78–86, e27–8. https://doi.org/10.1016/j.ijoa.2009.08.004; PMid:20194010

94. Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia 2015; 70:166–75. https://doi.org/10.1111/anae.12859; PMid:25289791

95. Plaat F, Bogod D, Bythell V, Mushambi M, Clyburn P, Lucas N, et al.; Association of Anaesthetists of Great Britain & Ireland; Obstetric Anaesthetists’ Association. OAA / AAGBI Guidelines for Obstetric Anaesthetic Services 2013. London: AAGBI; 2013.

96. National Institute for Health and Care Excellence. Detecting, managing and monitoring haemostasis: viscoelastometric point of care testing (ROTEM, TEG and Sonoclot systems). NICE diagnostics guidance 13. Manchester: NICE; 2014.

97. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, et al.; PPH Study Group. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007;5:266–73. https://doi.org/10.1111/j.1538-7836.2007.02297.x; PMid:17087729

98. Collins PW, Lilley G, Bruynseels D, Laurent DB, Cannings-John R, Precious E, et al. Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood 2014;124:1727–36. https://doi.org/10.1182/blood-2014-04-567891; PMid:25024304

99. de Lloyd L, Bovington R, Kaye A, Collis RE, Rayment R, Sanders J, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth 2011;20:135–41. https://doi.org/10.1016/j.ijoa.2010.12.002; PMid:21439811

100. Li G, Rachmale S, Kojicic M, Shahjehan K, Malinchoc M, Kor DJ, et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion 2011; 51:338–43. https://doi.org/10.1111/j.1537-2995.2010.02816.x; PMid:20723173 PMCid:PMC3006039

101. Teofili L, Bianchi M, Zanfini BA, Catarci S, Sicuranza R, Spartano S, et al. Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors. Mediterr J Hematol Infect Dis 2014; 6:e2014.069.

102. Collins PW, Solomon C, Sutor K, Crispin D, Hochleitner G, Rizoli S, etal. Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate. Br J Anaesth 2014; 113:585–95. https://doi.org/10.1093/bja/aeu086; PMid:25064078 PMCid:PMC4166889

103. Hiippala ST, Myllyl€a GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81:360–5. https://doi.org/10.1213/00000539-199508000-00026; https://doi.org/10.1097/00000539-199508000-00026; PMid:7542432

104. Chowdary P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125:69–73. https://doi.org/10.1111/j.1365-2141.2004.04868.x; PMid:15015971

105. Duguid J, O’Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, et al.; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004;126:11–28. https://doi.org/10.1111/j.1365-2141.2004.04972.x; PMid:15198728

106. Tikkanen M. Placental abruption: epidemiology, risk factors and consequences. Acta Obstet Gynecol Scand 2011;90:140–9. https://doi.org/10.1111/j.1600-0412.2010.01030.x; PMid:21241259

107. Levi M. Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism). Thromb Res 2013; 131 Suppl 1: S32–4. https://doi.org/10.1016/S0049-3848(13)70017-3

108. Green L, Knight M, Seeney F, Hopkinson C, Collins PW, Collis RE, et al. The haematological features and transfusion management of women who required massive transfusion for major obstetric haemorrhage in the UK: a population based study. Br J Haematol 2016;172:616–24. https://doi.org/10.1111/bjh.13864; PMid:26683982

109. Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth 2012;108:984–9. https://doi.org/10.1093/bja/aes096; PMid:22490316

110. De Lloyd L, Collins PW, Kaye A, Collis RE. Early fibrinogen as a predictor of red cell requirements during postpartum haemorrhage. Int J Obstet Anesth 2012;21 Suppl 1:S13.

111. Gayat E, Resche-Rigon M, Morel O, Rossignol M, Mantz J, Nicolas-Robin A, etal. Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Med 2011;37:1816–25. https://doi.org/10.1007/s00134-011-2315-0; PMid:21805157

112. Wikkelsш AJ, Edwards HM, Afshari A, Stensballe J, Langhoff-Roos J, Albrechtsen C, et al.; FIB-PPH trial group. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. Br J Anaesth 2015;114: 623–33. https://doi.org/10.1093/bja/aeu444; PMid:25586727

113. Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, etal. The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage – an observational study. Transfus Med 2012;22:344–9. https://doi.org/10.1111/j.1365-3148.2012.01178.x; PMid:22994449

114. Gollop ND, Chilcott J, Benton A, Rayment R, Jones J, Collins PW. National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemia. Transfus Med 2012; 22:350–5. https://doi.org/10.1111/j.1365-3148.2012.01168.x; PMid:22697297

115. Mallaiah S, Chevannes C, McNamara H, Barclay P. A reply. Anaesthesia 2015;70:760–1. https://doi.org/10.1111/anae.13272; https://doi.org/10.1111/anae.13128; PMid:25959192

116. Glover NJ, Collis RE, Collins P. Fibrinogen concentrate use during major obstetric haemorrhage. Anaesthesia 2010; 65: 1229–30. https://doi.org/10.1111/j.1365-2044.2010.06548.x; PMid:21182609

117. Weinkove R, Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med 2008;18:151–7. https://doi.org/10.1111/j.1365-3148.2008.00854.x; PMid:18598277

118. CRASH-2 collaborators, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096–101, 1101. e1–2.

119. Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H, et al.; The EXADELI Study Group. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 2011; 15:R117. https://doi.org/10.1186/cc10143; PMid:21496253 PMCid:PMC3219400

120. Shakur H, Elbourne D, G€ulmezoglu M, Alfirevic Z, Ronsmans C, Allen E, etal. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials 2010;11:40. https://doi.org/10.1186/1745-6215-11-40; PMid:20398351 PMCid:PMC2864262

121. Ahonen J. The role of recombinant activated factor VII in obstetric hemorrhage. Curr Opin Anaesthesiol 2012;25:309–14. https://doi.org/10.1097/ACO.0b013e3283532007; PMid:22473215

122. Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, et al. Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European Registry 2000–2004. Obstet Gynecol 2007; 110:1270–8. https://doi.org/10.1097/01.AOG.0000288515.48066.99; PMid:18055720

123. Franchini M, Franchi M, Bergamini V, Salvagno GL, Montagnana M, Lippi G. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage. Semin Thromb Hemost 2008; 34:104–12. https://doi.org/10.1055/s-2008-1066022; PMid:18393147

124. Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, et al. The use of recombinant activated FVII in postpartum hemorrhage. Clin Obstet Gynecol 2010;53: 219–27. https://doi.org/10.1097/GRF.0b013e3181cc4378; PMid:20142658

125. Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, et al. Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. J Thromb Haemost 2015;13:520–9. https://doi.org/10.1111/jth.12844; PMid:25594352

126. Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010; 363:1791–800. https://doi.org/10.1056/NEJMoa1006221; PMid:21047223

127. de Groot AN. Prevention of postpartum haemorrhage. Baillieres Clin Obstet Gynaecol 1995;9:619–31. https://doi.org/10.1016/S0950-3552(05)80385-2

128. Walker ID, Walker JJ, Colvin BT, Letsky EA, Rivers R, Stevens R; Haemostasis and Thrombosis Task Force. Investigation and management of haemorrhagic disorders in pregnancy. J Clin Pathol 1994;47:100–8. https://doi.org/10.1136/jcp.47.2.100; PMid:8132822 PMCid:PMC501820

129. Patel N, editor. Maternal Mortality – the Way Forward. Some Implications of the Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1985-87. London: RCOG; 1992.

130. Franchini M, Lippi G, Franchi M. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. BJOG 2007;114:8–15. https://doi.org/10.1111/j.1471-0528.2006.01156.x; PMid:17233855

131. Confidential Enquiry into Maternal and Child Health. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer – 2003-2005. The Seventh Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH; 2007.

132. Royal College of Obstetricians and Gynaecologists. Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. Green-top Guideline No. 37a. London: RCOG; 2015.

133. Palmer SK. Anaesthesia care for obstetric patients in the United States. In: Reynolds F, editor. Regional Analgesia in Obstetrics: A Millennium Update. London: Springer-Verlag London; 2000. pp. 3–10. https://doi.org/10.1007/978-1-4471-0435-3_1

134. Rajan PV, Wing DA. Postpartum hemorrhage: evidence-based medical interventions for prevention and treatment. Clin Obstet Gynecol 2010; 53: 165–81. https://doi.org/10.1097/GRF.0b013e3181ce0965; PMid:20142654

135. Joint Formulary Committee. British National Formulary, 69th ed. London: BMJ Group and Pharmaceutical Press; 2015.

136. Lewis G, editor. The National Institute for Clinical Excellence; The Scottish Executive Health Department; The Department of Health, Social Services and Public Safety: Northern Ireland. Why Mothers Die 1997–1999. The fifth report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: RCOG Press; 2001.

137. Buttino L Jr, Garite TJ. The use of 15 methyl F2 alpha prostaglandin (Prostin 15M) for the control of postpartum hemorrhage. Am J Perinatol 1986; 3:241–3. https://doi.org/10.1055/s-2007-999875; PMid:3487334

138. Oleen MA, Mariano JP. Controlling refractory atonic postpartum hemorrhage with Hemabate sterile solution. Am J Obstet Gynecol 1990;162:205–8. https://doi.org/10.1016/0002-9378(90)90851-W

139. Hofmeyr GJ, Walraven G, G€ulmezoglu AM, Maholwana B, Alfirevic Z, Villar J. Misoprostol to treat postpartum haemorrhage: a systematic review. BJOG 2005;112:547–53. https://doi.org/10.1111/j.1471-0528.2004.00512.x; PMid:15842275

140. Meckstroth KR, Whitaker AK, Bertisch S, Goldberg AB, Darney PD. Misoprostol administered by epithelial routes. Drug absorption and uterine response. Obstet Gynecol 2006; 108: 582–90. https://doi.org/10.1097/01.aog.0000230398.32794.9d

141. Tang J, Kapp N, Dragoman M, de Souza JP. WHO recommendations for misoprostol use for obstetric and gynecologic indications. Int J Gynaecol Obstet 2013;121:186–9. https://doi.org/10.1016/j.ijgo.2012.12.009; PMid:23433680

142. International Federation of Gynecology and Obstetrics. Treatment of Post-Partum Haemorrhage with Misoprostol. FIGO Guideline Annotated Version. London: FIGO; 2012. [www. k4health. org/toolkits/postpartumhemorrhage/treatment- post-partum-haemorrhage-misoprostol-figo-guideline-annotated]. Accessed 2016 Feb 4.

143. Georgiou C. Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG 2009; 116: 748–57. https://doi.org/10.1111/j.1471-0528.2009.02113.x; PMid:19432563

144. Ikechebelu JI, Obi RA, Joe-Ikechebelu NN. The control of ?postpartum haemorrhage with intrauterine Foley catheter. J Obstet Gynaecol 2005;25:70–2. https://doi.org/10.1080/01443610400025861; PMid:16147704

145. Bakri YN, Amri A, Abdul Jabbar F. Tamponade-balloon for ?obstetrical bleeding. Int J Gynaecol Obstet 2001;74:139–42. https://doi.org/10.1016/S0020-7292(01)00395-2

146. Chan C, Razvi K, Tham KF, Arulkumaran S. The use of a Sengstaken-Blakemore tube to control post-partum hemorrhage. Int J Gynaecol Obstet 1997;58:251–2. https://doi.org/10.1016/S0020-7292(97)00090-8

147. Condous GS, Arulkumaran S, Symonds I, Chapman R, Sinha A, Razvi K. The «tamponade test» in the management of massive postpartum hemorrhage. Obstet Gynecol 2003;101: 767–72. https://doi.org/10.1097/00006250-200304000-00026; https://doi.org/10.1016/S0029-7844(03)00046-2

148. Akhter S, Begum MR, Kabir Z, Rashid M, Laila TR, Zabeen F. Use of a condom to control massive postpartum hemorrhage. MedGenMed 2003;5:38. PMid:14600674

149. Keriakos R, Mukhopadhyay A. The use of the Rusch balloon for management of severe postpartum haemorrhage. J Obstet Gynaecol 2006; 26: 335–8. https://doi.org/10.1080/01443610600595077; PMid:16753685

150. Lennox C, Marr L; Reproductive Health Programme, Healthcare Impro-vement Scotland. Scottish Confi-dential Audit of Severe Maternal Morbidity: reducing avoidable harm. 10th Annual Report. Edinburgh: Healthcare Impro-vement Scotland; 2014.

151. Frenzel D, Condous GS, Papageorghiou AT, McWhinney NA. The use of the ‘tamponade test’ to stop massive obstetric haemorrhage in placenta accreta. BJOG 2005;112:676–7. https://doi.org/10.1111/j.1471-0528.2005.00491.x; PMid:15842298

152. Tindell K, Garfinkel R, Abu-Haydar E, Ahn R, Burke TF, Conn K, et al. Uterine balloon tamponade for the treatment of postpartum haemorrhage in resource-poor settings: a systematic review. BJOG 2013;120:5–14. https://doi.org/10.1111/j.1471-0528.2012.03454.x; PMid:22882240

153. Matsubara S, Yano H, Ohkuchi A, Kuwata T, Usui R, Suzuki M. Uterine compression sutures for postpartum hemorrhage: an overview. Acta Obstet Gynecol Scand 2013;92:378–85. https://doi.org/10.1111/aogs.12077; PMid:23330882

154. B-Lynch C, Coker A, Lawal AH, Abu J, Cowen MJ. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy Five cases reported. Br J Obstet Gynaecol 1997; 104:372–5. https://doi.org/10.1111/j.1471-0528.1997.tb11471.x; PMid:9091019

155. Harma M, Gungen N, Ozturk A. B-Lynch uterine compression suture for postpartum haemorrhage due to placenta praevia accreta. Aust N Z J Obstet Gynaecol 2005;45:93–5. https://doi.org/10.1111/j.1479-828X.2005.00340.x; PMid:15730380

156. Hayman RG, Arulkumaran S, Steer PJ. Uterine compression sutures: surgical management of postpartum hemorrhage. Obstet Gynecol 2002; 99:502–6. https://doi.org/10.1097/00006250-200203000-00022; https://doi.org/10.1016/S0029-7844(01)01643-X

157. Ghezzi F, Cromi A, Uccella S, Raio L, Bolis P, Surbek D. The Hayman technique: a simple method to treat postpartum haemorrhage. BJOG 2007; 114:362–5. https://doi.org/10.1111/j.1471-0528.2006.01204.x; PMid:17217361

158. Hwu YM, Chen CP, Chen HS, Su TH. Parallel vertical compression sutures: a technique to control bleeding from placenta praevia or accreta during caesarean section. BJOG 2005; 112:1420–3. https://doi.org/10.1111/j.1471-0528.2005.00666.x; PMid:16167948

159. Kafali H, Demir N, Soylemez F, Yurtseven S. Hemostatic cervical suturing technique for management of uncontrollable postpartum haemorrhage originating from the cervical canal. Eur J Obstet Gynecol Reprod Biol 2003;110:35–8. https://doi.org/10.1016/S0301-2115(03)00104-0

160. Makino S, Tanaka T, Yorifuji T, Koshiishi T, Sugimura M, Takeda S. Double vertical compression sutures: A novel conservative approach to managing post-partum haemorrhage due to placenta praevia and atonic bleeding. Aust N Z J Obstet Gynaecol 2012; 52:290–2. https://doi.org/10.1111/j.1479-828X.2012.01422.x; PMid:22413844

161. Аyem G, Kurinczuk JJ, Alfirevic Z, Spark P, Brocklehurst P, Knight M; U.K. Obstetric Surveillance System (UKOSS). Uterine compression sutures for the management of severe postpartum hemorrhage. Obstet Gynecol 2011; 117:14–20.

162. Fotopoulou C, Dudenhausen JW. Uterine compression sutures for preserving fertility in severe postpartum haemorrhage: an overview 13 years after the first description. J Obstet Gynaecol 2010;30:339–49. https://doi.org/10.3109/01443611003650233; PMid:20455714

163. Diemert A, Ortmeyer G, Hollwitz B, Lotz M, Somville T, Glosemeyer P, et al. The combination of intrauterine balloon tamponade and the B-Lynch procedure for the treatment of severe postpartum hemorrhage. Am J Obstet Gynecol 2012;206:65.e1–4. https://doi.org/10.1016/j.ajog.2011.07.041; PMid:22000893

164. Yoong W, Ridout A, Memtsa M, Stavroulis A, Aref-Adib M, Ramsay-Marcelle Z, et al. Application of uterine compression suture in association with intrauterine balloon tamponade (‘uterine sandwich’) for postpartum hemorrhage. Acta Obstet Gynecol Scand 2012;91:147–51. https://doi.org/10.1111/j.1600-0412.2011.01153.x; PMid:21501126

165. Nelson WL, O’Brien JM. The uterine sandwich for persistent uterine atony: combining the B-Lynch compression suture and an intrauterine Bakri balloon. Am J Obstet Gynecol 2007; 196: e9–10. https://doi.org/10.1016/j.ajog.2006.10.887; PMid:17466689

166. AbdRabbo SA. Stepwise uterine devascularization: a novel technique for management of uncontrolled postpartum hemorrhage with preservation of the uterus. Am J Obstet Gynecol 1994; 171: 694–700. https://doi.org/10.1016/0002-9378(94)90084-1

167. Sentilhes L, Gromez A, Descamps P, Marpeau L. Why stepwise uterine devascularization should be first-line conservative surgical treatment to control severe postpartum hemorrhage? Acta Obstet Gynecol Scand 2009; 88:490–2. https://doi.org/10.1080/00016340902792441

168. Joshi VM, Otiv SR, Majumder R, Nikam YA, Shrivastava M. Internal iliac artery ligation for arresting postpartum haemorrhage. BJOG 2007; 114: 356–61. https://doi.org/10.1111/j.1471-0528.2006.01235.x; PMid:17261120

169. Nizard J, Barrinque L, Frydman R, Fernandez H. Fertility and pregnancy outcomes following hypogastric artery ligation for severe post-partum haemorrhage. Hum Reprod 2003;18:844–8. https://doi.org/10.1093/humrep/deg161; PMid:12660282

170. Doumouchtsis SK, Nikolopoulos K, Talaulikar VS, Krishna A, Arulkumaran S. Menstrual and fertility outcomes following the surgical management of postpartum haemorrhage: a systematic review. BJOG 2014; 121: 382–8. https://doi.org/10.1111/1471-0528.12546; PMid:24321038

171. Lee HY, Shin JH, Kim J, Yoon HK, Ko GY, Won HS, et al. Primary postpartum hemorrhage: outcome of pelvic arterial embolization in 251 patients at a single institution. Radiology 2012; 264: 903–9. https://doi.org/10.1148/radiol.12111383; PMid:22829685

172. Salomon LJ, de Tayrac R, Castaigne-Meary V, Audibert F, Musset D, Ciorascu R, et al. Fertility and pregnancy outcome following pelvic arterial embolization for severe post-partum haemorrhage. A cohort study. Hum Reprod 2003; 18:849–52. https://doi.org/10.1093/humrep/deg168; PMid:12660283

173. Descargues G, Mauger Tinlot F, Douvrin F, Clavier E, Lemoine JP, Marpeau L. Menses, fertility and pregnancy after arterial embolization for the control of postpartum haemorrhage. Hum Reprod 2004;19:339–43. https://doi.org/10.1093/humrep/deh082; PMid:14747177

174. Fargeaudou Y, Morel O, Soyer P, Gayat E, Sirol M, Boudiaf M, et al. Persistent postpartum haemorrhage after failed arterial ligation: value of pelvic embolisation. Eur Radiol 2010;20:1777–85. https://doi.org/10.1007/s00330-010-1713-y; PMid:20309561

175. Brace V, Kernaghan D, Penney G. Learning from adverse clinical outcomes: major obstetric haemorrhage in Scotland, 2003–05. BJOG 2007; 114: 1388–96. https://doi.org/10.1111/j.1471-0528.2007.01533.x; PMid:17949379

176. Duffy S, Gaffney G. Maternal admissions to ICU – time to re– evaluate. Ir Med J 2001;94:248–9. PMid:11758629

177. Neill A, Thornton S. Secondary postpartum haemorrhage. J Obstet Gynaecol 2002;22:119–22. https://doi.org/10.1080/01443610120113238; PMid:12521690

178. Babarinsa IA, Hayman RG, Draycott TJ. Secondary post-partum haemorrhage: challenges in evidence-based causes and management. Eur J Obstet Gynecol Reprod Biol 2011; 159:255–60. https://doi.org/10.1016/j.ejogrb.2011.07.029; PMid:21839573

179. Rome RM. Secondary postpartum haemorrhage. Br J Obstet Gynaecol 1975;82:289–92. https://doi.org/10.1111/j.1471-0528.1975.tb00636.x; PMid:1079136

180. Pather S, Ford M, Reid R, Sykes P. Postpartum curettage: an audit of 200 cases. Aust N Z J Obstet Gynaecol 2005;45:368–71. https://doi.org/10.1111/j.1479-828X.2005.00445.x; PMid:16171469

181. French L, Smaill FM. Antibiotic regimens for endometritis after delivery. Cochrane Database Syst Rev 2004; (4):CD001067. https://doi.org/10.1002/14651858.cd001067.pub2

182. Royal College of Obstetricians and Gynaecologists. Bacterial Sepsis following Pregnancy. Green-top Guideline No. 64b. London: RCOG; 2012.

183. Carlan SJ, Scott WT, Pollack R, Harris K. Appearance of the uterus by ultrasound immediately after placental delivery with pathologic correlation. J Clin Ultrasound 1997;25:301–8. https://doi.org/10.1002/(SICI)1097-0096(199707)25:6<301::AID-JCU3>3.0.CO;2-G

184. de Vries JI, van der Linden RM, van der Linden HC. Predictive value of sonographic examination to visualize retained placenta directly after birth at 16 to 28 weeks. J Ultrasound Med 2000; 19:7–12. https://doi.org/10.7863/jum.2000.19.1.7; PMid:10625184

185. Edwards A, Ellwood DA. Ultrasonographic evaluation of the postpartum uterus. Ultrasound Obstet Gynecol 2000;16:640–3. https://doi.org/10.1046/j.1469-0705.2000.00234.x; PMid:11169371

186. Sadan O, Golan A, Girtler O, Lurie S, Debby A, Sagiv R, et al. Role of sonography in the diagnosis of retained products of conception. J Ultrasound Med 2004;23:371–4. https://doi.org/10.7863/jum.2004.23.3.371; PMid:15055784

187. Mulic-Lutvica A, Axelsson O. Ultrasound finding of an echogenic mass in women with secondary postpartum hemorrhage is associated with retained placental tissue. Ultrasound Obstet Gynecol 2006;28:312–9. https://doi.org/10.1002/uog.2849; PMid:16888708

188. Yi SW, Ahn JH. Secondary postpartum hemorrhage due to a pseudoaneurysm rupture at the fundal area of the uterus: a case treated with selective uterine arterial embolization. Fertil Steril 2010;93:2048–9. https://doi.org/10.1016/j.fertnstert.2009.03.099; PMid:19423103

189. Arab TS, Dy J. Pseudoaneurysm of the vaginal artery as a cause of postpartum haemorrhage. J Obstet Gynaecol 2011;31: 185–6. https://doi.org/10.3109/01443615.2010.542514; PMid:21281042

190. Chitra TV, Panicker S. Pseudo-aneurysm of uterine artery: a rare cause of secondary postpartum hemorrhage. J Obstet Gynaecol India 2011; 61: 641–4. https://doi.org/10.1007/s13224-011-0096-6; PMid:23204681 PMCid:PMC3307934

191. King PA, Duthie SJ, Dong ZG, Ma HK. Secondary postpartum haemorrhage. Aust N Z J Obstet Gynaecol 1989;29:394–8. https://doi.org/10.1111/j.1479-828X.1989.tb01776.x; PMid:2631675

192. Jensen PA, Stromme WB. Amenorrhea secondary to puerperal curettage (Asherman’s syndrome). Am J Obstet Gynecol 1972;113:150–7. https://doi.org/10.1016/0002-9378(72)90764-8

193. Sharma AM, Burbridge BE. Uterine artery pseudoaneurysm in the setting of delayed postpartum hemorrhage: successful treatment with emergency arterial embolization. Case Rep Radiol 2011;2011:373482. https://doi.org/10.1155/2011/373482; PMid:22606544 PMCid:PMC3350022

194. Agrawal R, Legge F, Pollard K, Al-Inizi S. Massive secondary postpartum haemorrhage managed with insertion of a Bakri balloon catheter after surgical evacuation of the uterus. S Afr J Obstet Gynaecol 2011;17:36–7.

195. Meri en AE, van de Ven J, Mol BW, Houterman S, Oei SG. Multidisciplinary team training in a simulation setting for acute obstetric emergencies: a systematic review. Obstet Gynecol 2010; 115: 1021–31. https://doi.org/10.1097/AOG.0b013e3181d9f4cd; PMid:20410778

196. Royal College of Obstetricians and Gynaecologists. Improving Patient Safety: Risk Management for Maternity and Gynaecology. Clinical Governance Advice No. 2. London: RCOG; 2009.

197. Penney G, Brace V. Near miss audit in obstetrics. Curr Opin Obstet Gynecol 2007;19:145–50. https://doi.org/10.1097/GCO.0b013e328014a860; PMid:17353683

198. Beck CT. Post-traumatic stress disorder due to childbirth: the aftermath. Nurs Res 2004;53:216–24. https://doi.org/10.1097/00006199-200407000-00004; PMid:15266160

199. Dokmeta’s HS, Kilicli F, Korkmaz S, Yonem O. Characteristic features of 20 patients with Sheehan’s syndrome. Gynecol Endocrinol 2006;22:279–83. https://doi.org/10.1080/09513590600630504; PMid:16785150

Содержание журнала Текст статьи